Philip PAM GORWOOD

Prof. Philip PAM GORWOOD

GHU Paris Psychiatrie et Neurosciences, Paris, Île-de-France, France
+1
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2012 in Nature Reviews Drug Discovery
Verified
Journal Article
Closed access
PDF file
MMMark J. Millan
Mark J. Millan
YAYves Agid
Yves Agid
MBMartin Brüne
Martin Brüne
EBEdward T. Bullmore
Edward T. Bullmore
CCCameron S. Carter
Cameron S. Carter
LYLarry J. Young
Larry J. Young

1 January 2019 in European Psychiatry
Verified
Journal Article
Closed access
AFAriel Frajerman
Ariel Frajerman
YMYannick Morvan
Yannick Morvan
MKMarie-Odile Krebs
Marie-Odile Krebs
Philip PAM GORWOODPhilip PAM GORWOOD
Philip PAM GORWOOD
BCBoris Chaumette
Boris Chaumette
Background: Applying the concept of burnout to medical students before residency is relatively recent. Its estimated prevalence varies significantly between studies. Our objective was to estimate the prevalence of burnout in medical students worldwide.Methods: We systematically searched Medline for English-language articles published between January 1, 2010 and December 31, 2017. We selected all the original studies about the prevalence of burnout in medical students before residency, using validated questionnaires for burnout. Statistical analyses were conducted using the OpenMetaAnalyst software.Results: Prevalence of current burnout was extracted from 24 studies encompassing 17,431 medical students. Among them, 8060 suffered from burnout and we estimated the prevalence to be 44.2% [33.4%–55.0%]. The information about the prevalence of each subset of burnout dimensions was given in nine studies including 7588 students. Current prevalence was estimated to be 40.8% for ‘emotional exhaustion’ [32.8%–48.9%], 35.1% [27.2%–43.0%] for ‘depersonalization’ and 27.4% [20.5%–34.3%] for ‘personal accomplishment’. There is no significant gender difference in burnout. The prevalence of burnout is slightly different across countries with a higher prevalence in Oceania and the Middle East than in other continents.Conclusions: The results of this meta-analysis suggest that one student out of two is suffering from burnout, even before residency. Again, our findings highlight the high level of distress in the medical population. These results should encourage the development of preventive strategies.

1 July 2021 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Closed access
MMMaxime Marvaldi
Maxime Marvaldi
JMJasmina Mallet
Jasmina Mallet
CDCaroline Dubertret
Caroline Dubertret
MMMarie Rose Moro
Marie Rose Moro
SGSélim Benjamin Guessoum
Sélim Benjamin Guessoum

11 February 2014 in CNS Spectrums
Verified
Journal Article
Closed access
PDF file
NFNaomi A Fineberg
Naomi A Fineberg
SCSamuel R. Chamberlain
Samuel R. Chamberlain
AGAnna E. Goudriaan
Anna E. Goudriaan
DSDan J. Stein
Dan J. Stein
LVLouk J. M. J. Vanderschuren
Louk J. M. J. Vanderschuren
MPMarc N. Potenza
Marc N. Potenza
Impulsivity and compulsivity represent useful conceptualizations that involve dissociable cognitive functions, which are mediated by neuroanatomically and neurochemically distinct components of cortico-subcortical circuitry. The constructs were historically viewed as diametrically opposed, with impulsivity being associated with risk-seeking and compulsivity with harm-avoidance. However, they are increasingly recognized to be linked by shared neuropsychological mechanisms involving dysfunctional inhibition of thoughts and behaviors. In this article, we selectively review new developments in the investigation of the neurocognition of impulsivity and compulsivity in humans, in order to advance our understanding of the pathophysiology of impulsive, compulsive, and addictive disorders and indicate new directions for research.

11 February 2014 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
VBV Boraska
V Boraska
CFC S Franklin
C S Franklin
JFJ A B Floyd
J A B Floyd
LTL M Thornton
L M Thornton
LHL M Huckins
L M Huckins
PWPamela Whittaker
Pamela Whittaker

1 February 2009 in Behavioural Pharmacology
Verified
Journal Article
Closed access
Bernard Le FollBernard Le Foll
Bernard Le Foll
AGAlexandra Gallo
Alexandra Gallo
YSYann Le Strat
Yann Le Strat
LLLin Lu
Lin Lu
Philip PAM GORWOODPhilip PAM GORWOOD
Philip PAM GORWOOD
Drug dependence is a chronic, relapsing disorder in which compulsive drug-seeking and drug-taking behaviours persist despite serious negative consequences. Addictive substances, such as opioids, ethanol, psychostimulants and nicotine, induce pleasant states or relieve distress, effects that contribute to their recreational use. Dopamine is critically involved in drug addiction processes. However, the role of the various dopaminergic receptor subtypes has been difficult to delineate. Here, we will review the information collected implicating the receptors of the D1 family (DRD1 and DRD5) and of the D2 family (DRD2, DRD3 and DRD4) in drug addiction. We will summarize the distribution of these receptors in the brain, the preclinical experiments carried out with pharmacological and transgenic approaches and the genetic studies carried out linking genetic variants of these receptors to drug addiction phenotypes. A meta-analysis of the studies carried out evaluating DRD2 and alcohol dependence is also provided, which indicates a significant association. Overall, this review indicates that different aspects of the addiction phenotype are critically influenced by dopaminergic receptors and that variants of those genes seem to influence some addiction phenotypes in humans.